Alzheimer's treatment 'benefits patients with severe disease'

Taking the cholinesterase inhibitor galantamine has been shown for the first time to improve cognitive function in patients with severe Alzheimer's disease, according to UK research.

Currently, the drug is only prescribed to patients with mild to moderate Alzheimer's, and stopped when their condition deteriorates to the severe stage.

For this latest study, the researchers randomly assigned 407 patients with severe Alzheimer's who were living in a nursing home to receive galantamine, 24mg daily, or placebo for six months.

Overall, the researchers found that patients who were given galantamine had improved cognitive function, particularly memory and the ability to carry out motor performance tasks.

However, the carers who were looking after the patients reported that those on galantamine showed no improvement in their ability to undertake everyday tasks, compared with the patients on placebo.

The researchers, from the University of Manchester, said: 'The data shows there are untreated patients with severe Alzheimer's disease in nursing homes who could benefit from starting treatment with galantamine.'

But in an editorial, Dr Martin Farlow, from Indiana University, warned that the 'clinical usefulness of galantamine has still not been proven in this population'.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GMC to restart fitness to practise cases and PLAB tests within weeks

GMC to restart fitness to practise cases and PLAB tests within weeks

Fitness to practise cases paused during the coronavirus pandemic will restart this...

NHS England confirms plan to add practice managers to £20,000 golden hello scheme

NHS England confirms plan to add practice managers to £20,000 golden hello scheme

NHS England hopes to extend the £20,000 golden hello scheme for first-time partners...

COVID-19 risk assessments could devastate fragile GP workforce in parts of England

COVID-19 risk assessments could devastate fragile GP workforce in parts of England

COVID-19 risk assessments could devastate the threadbare primary care workforce in...

GP trainees still paying thousands for NHS levy Boris Johnson promised to scrap

GP trainees still paying thousands for NHS levy Boris Johnson promised to scrap

GP trainees are among overseas NHS staff continuing to face demands for thousands...

GP fear surge of avoidable illness as patients skip routine vaccinations in pandemic

GP fear surge of avoidable illness as patients skip routine vaccinations in pandemic

Patients have been urged not to skip routine vaccination amid concerns the COVID-19...

GPs plan drive-through flu clinics amid COVID-19 safety fears

GPs plan drive-through flu clinics amid COVID-19 safety fears

GP practices are planning drive-through flu clinics to maximise uptake of jabs during...